Meridian Bioscience reported $1.3B in Market Capitalization this June of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Abbott ABT:US $ 207.24B 41.63B
Accelerate Diagnostics AXDX:US 0.1B 0.25B
Antares Pharma ATRS:US $ 0.7B 0.09B
Atrion ATRI:US 1.27B 0.01B
Becton, Dickinson and BDX:US $ 75.83B 4.21B
Bio Rad Laboratories BIO:US $ 16.98B 5.46B
Cerulean Pharma CERU:US $ 0.12B 0.04B
Cerus CERS:US $ 0.95B 0.22B
Meridian Bioscience VIVO:US $ 1.13B 0.24B
Myriad Genetics MYGN:US $ 2.02B 0.19B
Neogen NEOG:US $ 3.32B 1.57B
Orasure Technologies OSUR:US $ 0.5B 0.12B
Quidel QDEL:US $ 4.71B 0.92B
Rockwell Medical RMTI:US $ 0.04B 0B
Sientra SIEN:US $ 0.14B 0.07B
Staar Surgical STAA:US $ 3.82B 0.53B
Thermo Fisher Scientific TMO:US $ 231.2B 31.72B
Trinity Biotech TRIB:US 0.02B 0.01B
Utah Medical Products UTMD:US $ 0.34B 0.02B